GSA Capital Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-324,784
| Closed | -$386K | – | 2010 |
|
2022
Q3 | $386K | Buy |
+324,784
| New | +$386K | 0.05% | 769 |
|
2022
Q2 | – | Sell |
-279,605
| Closed | -$319K | – | 1921 |
|
2022
Q1 | $319K | Buy |
+279,605
| New | +$319K | 0.04% | 853 |
|
2021
Q4 | – | Sell |
-89,878
| Closed | -$307K | – | 1910 |
|
2021
Q3 | $307K | Sell |
89,878
-127,809
| -59% | -$437K | 0.03% | 1001 |
|
2021
Q2 | $651K | Buy |
+217,687
| New | +$651K | 0.07% | 464 |
|
2018
Q4 | – | Sell |
-284,354
| Closed | -$771K | – | 1844 |
|
2018
Q3 | $771K | Sell |
284,354
-5,500
| -2% | -$14.9K | 0.04% | 840 |
|
2018
Q2 | $554K | Sell |
289,854
-12,300
| -4% | -$23.5K | 0.03% | 1106 |
|
2018
Q1 | $635K | Buy |
302,154
+288,500
| +2,113% | +$606K | 0.03% | 948 |
|
2017
Q4 | $28K | Buy |
+13,654
| New | +$28K | ﹤0.01% | 1514 |
|
2015
Q2 | – | Sell |
-19,446
| Closed | -$272K | – | 2239 |
|
2015
Q1 | $272K | Buy |
+19,446
| New | +$272K | 0.01% | 1767 |
|